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a b s t r a c t
Dengue is the most signiﬁcant arthropod borne viral disease worldwide, and infectionwith the dengue virus
causes a wide range of symptoms in humans, including bone marrow suppression. While the target cells of
the virus remain poorly characterized, cells of the myeloid lineage have been shown to be important
mediators of the disease. This study sought to determine whether erythroid precursor cells were susceptible
to dengue virus infection, and whether erythroid cells from thalassemia trait carriers showed any protection
against infection. Infection with a laboratory adapted high passage DENV-2 resulted in high levels of
infection during certain stages of differentiation, and cells derived from thalassemia trait carriers showed
signiﬁcantly reduced susceptibility to dengue virus infection. Infection with low passage isolates resulted in
only scattered cells showing evidence of infection, but high bystander apoptosis that was reduced by both a
caspase 8 inhibitor and anti-tumor necrosis factor 1 receptor antibodies.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Dengue virus (DENV) is recognized as the most common arthro-
pod borne human viral pathogen and is endemic in many tropical
and subtropical countries. The virus belongs to family Flaviviridae,
genus Flavivirus and possesses a positive sense single stranded RNA
genome. Four serotypes of DENV have been classiﬁed, namely
DENV-1, DENV-2, DENV-3 and DENV-4. Human infection with the
virus occurs after the bite of an infected female mosquito and results
in a broad range of clinical manifestations including fever, rash and
headache as well as muscle and joint pain (Gubler, 1998). Early bone
marrow suppression, thrombocytopenia and leukopenia are clinical
hallmarks in dengue patients, but the etiology remains unclear
(Bierman and Nelson, 1965; Srichaikul and Nimmannitya, 2000).
Infection of the bone marrow has been suggested as a contributing
factor as this compartment is the major site for hematopoiesis and
bone marrow infection was found in in vivo studies of non-human
primates, and it was proposed that megakaryocytes are the major
target for DENV in this compartment (Noisakran et al., 2012).
Pluripotent hematopoietic stem cells (HSCs) located in the bone
marrow give rise to lymphoid (natural killer (NK), T and B cells) and
myeloid (granulocyte, monocyte, dendritic, erythrocyte and mega-
karyocyte) cells (Gunsilius et al., 2001), and several cells of the
myeloid lineage including dendritic cells (Wu et al., 2000), mono-
cytes (Scott et al., 1980) and megakaryocytes (Noisakran et al., 2012)
have been shown to be susceptible to dengue virus infection. Mature
erythroid cells arise from hematopoietic stem cells which give rise to
early erythroid committed progenitor cells (burst forming units-
erythroid or BFU-E) which subsequently give rise to late erythroid
progenitor cells (colony forming units-erythroid or CFU-E) which
further differentiate to erythroid committed precursors which con-
sist of a series of erythroblastic cells (proerythroblasts, basophilic
erythroblasts, polychromatic erythroblasts, orthochromatic erythro-
blasts and reticulocytes) which ﬁnally develop into mature erythro-
cytes (Gunsilius et al., 2001). While previous in vitro studies have
shown that hematopoietic progenitor cells are susceptible to DENV
infection and inhibition of cell proliferation has been observed
(Murgue et al., 1997; Nakao et al., 1989), no study has to date
investigated the susceptibility to DENV infection of the more diff-
erentiated erythroid precursor cells.
Erythroid cells have been well characterized as a target for mos-
quito borne protozoan parasite Plasmodium spp., which are respon-
sible for the disease malaria (Garcia, 2010) and the protective effects
of hemoglobin variants or globin gene deletions has been well
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established (Taylor et al., 2012). For example heterozygous sickle
cell traits have been well characterized as providing a protective
advantage against malaria in endemic areas (Aidoo et al., 2002;
Allison, 1954; Piel et al., 2010; Williams et al., 2005). Similarly,
αþ-thalassemia traits have been proposed as another determinant
that may provide protection against severe malaria (Enevold et al.,
2007; Mockenhaupt et al., 2004; Wambua et al., 2006). These
studies support the malaria hypothesis which proposes that it is
the selective pressure provided by the malaria parasite that main-
tains the sickle cell and thalassemia traits in populations (Clegg and
Weatherall, 1999). In some areas of the world, and particularly in
Southeast Asia, thalassemia traits are found in the population at
extremely high levels (Fucharoen and Winichagoon, 1992). In parts
of Thailand the hemoglobin variant Hb E is found in up to 50% of
the population and other traits show similarly high penetrance
(Fucharoen and Winichagoon, 1992). It is possible therefore that
other mechanisms besides malaria are providing selective pressure
on maintaining these traits in the population. This study sought to
determine whether erythroid precursor cells were susceptible to
DENV infection, and whether thalassemia traits resulted in any
modulation of DENV infectivity.
Materials and methods
Cells and virus
LLC-MK2 cells were grown in Dulbecco's modiﬁed Eagle medium
(DMEM; Gibco BRL, Gaithesburg, MD) supplemented with 5% heat
inactivated fetal bovine serum (FBS; Gibco BRL) and 100 units/mL of
penicillin/streptomycin (PAA Laboratories GmbH, Pasching, Austria).
The human erythroleukemia cell line K562 was grown in RPMI-
1640 (Gibco BRL) supplemented with 10% FBS and 100 units/mL of
penicillin/streptomycin. Both cell lines were incubated at 37 1C with
5% CO2. Dengue virus serotype 2 (DENV-2; strain 16681; GenBank
accession number M84727.1), Dengue virus serotype 2 (DENV-2
DHF; DENV-2/THAI/NS1-141/2006; GenBank Accession number
KM519587) and Dengue virus serotype 4 (DENV-4 DF; DENV-4/
THAI/NS1-058/2006; GenBank accession number KM519591) were
used in this study. DENV-2/THAI/NS1-141/2006 and DENV-4/THAI/
NS1-058/2006 were passaged 3 times through C6/36 cells prior to
use in this study. All dengue viruses were propagated in C6/36 cells
(ATCC CRL-1660) and chikungunya virus (CHIKV) ECSA 226V
genotype was propagated in Vero (ATCC: CCL-81) cells as described
elsewhere (Wikan et al., 2012). The supernatants were partially
puriﬁed by centrifugation and stored at 80 1C as viral stock. All
virus titers were determined by standard plaque assay on LLC-MK2
cells or Vero cells as previously described (Sithisarn et al., 2003).
Sample collection and erythroid cell culture
The study was performed in accordance with the Helsinki
Declaration and was conducted after approval by the Ethical
Committee, Mahidol University Institutional Review Board. Writ-
ten informed consent was obtained from all subjects. Complete
blood count (CBC) indices, hemoglobin typing and α-globin gene
genotyping were used to classify thalassemia carriers and normal
controls. Fifty milliliter of peripheral blood was taken from at least
three individuals per group which were classiﬁed either as normal
subject, β-thalassemia trait, Hb E trait or α-thalassemia 1 trait.
CD34þ hematopoietic stem cells (HSCs) were isolated from peri-
pheral blood samples and cultured under conditions that pro-
duced differentiation in the erythroid lineage as described in
previously (Lithanatudom et al., 2010; Wannatung et al., 2009)
and see more detail in Supplemental materials and methods.
Under these growth conditions more than 95% of cells show
erythroblast morphology as established previously (Wannatung
et al., 2009). Cell numbers were established by trypan blue
exclusion assay and counting using a cell counting chamber.
Virus infection
Cells (K562 cells or erythroid committed progenitor or precursor
cells) were cultured in 6-well culture plates or 12-well culture
plates under standard conditions and were infected with DENV-2
strain 16681 at various multiplicity of infection (m.o.i.) and DENV-2
DHF and DENV-4 DF at m.o.i. 50. Some normal erythroid committed
precursor cells were infected with CHIKV at m.o.i. 0.1, 1 and 5. Cells
and virus were incubated for 2 h in normal mediumwithout serum
albumin with occasional agitation after which complete medium
was added and cells were incubated under standard conditions
until required. In some experiments DENV-2 was pre-incubated for
1 h at 4 oC with a 1:100 dilution of a mouse monoclonal anti-DENV
E protein antibody produced by hybridoma HB114 (Henchal et al.,
1982) before addition to cells as described elsewhere (Klomporn
et al., 2011). For viral production measurement, after 2 h of incuba-
tion, unbound virus was washed 4 times with IMDM medium
without serum albumin. Supernatant was collected at several time
points and virus titer was measured.
Flow cytometry, indirect immunoﬂuorescence assay and
immunocytochemical staining
Flow cytometry and indirect immunoﬂuorescence were under-
taken essentially as described elsewhere (Leecharoenkiat et al.,
2011; Lithanatudom et al., 2010; Panyasrivanit et al., 2009). Imm-
unocytochemical staining was performed using a Vectastain ABC
kit following the manufacturer's protocol and counterstained with
Wright–Giemsa staining. For full details, see ﬁle Supplemental
materials and methods.
Western blot analysis
Supernatant was collected from DENV-2 infected cells. Total
protein was extracted from mock infected and infected cells. Pro-
teins were subjected to western blot analysis exactly as described
previously (Leecharoenkiat et al., 2011). For further details, see ﬁle
Supplemental materials and methods.
Caspase 8 inhibition
Day 7 erythroid precursor cells were pretreated with or without
10 mM of Caspase 8 inhibitor (Z-Ile-Glu(O-ME)-Thr-Asp(O-Me) ﬂuor-
omethyl ketone; Sigma-Aldrich, St. Louis, MO) and incubated at
37 1C, 5% CO2 with agitation for 2 h. Incubated cells were infected
with DENV-4 DF with or without 10 mM of Caspase 8 inhibitor. After
2 h of viral incubation, complete IMDM medium with or without a
ﬁnal concentration of 10 mM of Caspase 8 inhibitor was added and
cells were subsequently incubated at 37 1C with 5% CO2 for 48 h.
TNF-R1 receptor blocking
Erythroid precursor cells were infected with DENV-2 DHF under
the standard protocol and at 6 h post infection the medium was
supplemented an anti-TNF-R1 (sc-7895; Santa Cruz Biotechnology Inc.,
Dallas, TX) antibody to ﬁnal concentrations of 5 mg⧸mL. An identical
amount of antibody was added at 24 h post infection. Treated and
untreated cells were incubated under standard conditions.
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Statistical analysis
Statistical analysis was performed by using PASW statistics
version 18 (SPSS Inc., Chicago, IL). Data was analyzed by indepen-
dent or paired sample t- tests as appropriate and a p value o0.05
was considered as signiﬁcant.
Results
DENV-2 infection of K562 cells and normal erythroid cells
The human erythromyeloblastoid leukemia cell line K562 is
frequently used as a model for erythroid cell studies, and the cells
can give rise to erythroid cells under appropriate induction (Osti et al.,
1997; Rutherford et al., 1979). We therefore initially validated the
susceptibility of this cell line to DENV infection as has been shown by
others (Goncalvez et al., 2007) under both conditions of direct
infection and under conditions of ADE infection (in which entry is
mediated through the Fc receptor). Cells were therefore either directly
exposed to DENV, or exposed to a DENV/antibody complex at m.o.i. of
1, 10 and 50 and after 48 h the percentage of infected cells was
determined by ﬂow cytometry. Results showed that K562 cells were
able to be directly infected by DENV, and that signiﬁcantly increased
levels of infection were seen when the DENV was complexed with a
non-neutralizing anti-DENV E protein antibody (Fig. 1A), consistent
with the reports of others (Goncalvez et al., 2007).
We next determined the susceptibility of selected normal control
CD34þ HSCs from two donors that had been cultured for 4 days
(which corresponds to the erythroid committed progenitor stage) to
be infected by DENV under conditions of direct infection and ADE
infection with infectivity determined by ﬂow cytometry as above
at 48 h post infection. Results (Fig. 1B) showed infection of day
4 erythroid progenitor cells that increased with increasing m.o.i.
between 1 and 50, and that no increase of infectivity was seenwhen
cells were infected under conditions of ADE, suggesting that infec-
tion occurs by direct infection, and not through Fc receptor mediated
internalization. These results are consistent with the earlier observa-
tions of others (Murgue et al., 1997; Nakao et al., 1989).
DENV-2 infection of erythroid precursor cells
To investigate the susceptibility of erythroid committed pre-
cursor cells, CD34þ HSCs were selected and cultured for 7 and 10
days under conditions that drive erythropoiesis (Leecharoenkiat
et al., 2011; Lithanatudom et al., 2010; Wannatung et al., 2009) and
infected with DENV at m.o.i. 50. At 48 h post infection (p.i.), the
degree of cell infection was determined by ﬂow cytometry. Results
(Fig. 1C and D) showed that nearly 80% of the cells infected on day
7 were infected, while approximately 40% of cells cultured for 10
days prior to infection were infected which is similar to the levels
seen when day 4 cells (erythroid progenitor) were infected. We
additionally analyzed infection of erythroid committed precursor
cells from thalassemia carriers to DENV-2 infection and CD34þ
HSCs were isolated from 3 individuals each of Hb E trait, β-thal-
assemia trait and α-thalassemia 1 trait and cultured for 7 or 10
days and infected with DENV-2, and samples were analyzed by
ﬂow cytometry at 48 h p.i. The results showed that erythroid
committed precursor cells from all three traits were susceptible
to infection, and, as with control erythroblast, higher levels of
infection were seen in cells infected at day 7 as compared to day
10 (Fig. 1C and D). While no difference was seen in the level
of infection between erythroblasts infected on day 10 of cul-
ture (Fig. 1D), all three traits showed signiﬁcantly lower levels of
infection (po0.05) as compared to normal control cells when day
7 cells were infected (Fig. 1C), with the lowest level of infection
being seen in cells isolated from thalassemia carriers of α-thal-
assemia 1. We additionally determined whether normal control
day 7 erythroid committed precursor cells were susceptible to in-
fection with CHIKV using m.o.i. 0.1, 1 and 5 and the results reve-
aled that these cells were not susceptible to CHIKV infection (data
not shown).
Differentiation of erythroid committed precursor cells
Culture of isolated CD34þ HSCs for 7 to 10 days results in a
pool of cells at different stages of differentiation (proerythroblasts,
basophilic erythroblasts, polychromatic erythroblasts, orthochro-
matic erythroblasts) as shown previously (Leecharoenkiat et al.,
2011). To determine whether the reduced infection could result
from altered differentiation of erythroid committed precursor cells
from thalassemia carriers, the differentiation of normal control
cells was compared to cells isolated from α-thalassemia 1 carriers.
Day 7 and day 10 erythroid precursor cells from three α-thal-
assemia 1 carriers and three normal controls were stained with
antibodies directed against CD71 and glycophorin A and analyzed
by ﬂow cytometry. Cell populations were gated to R1-R4 areas
according to erythroid cell maturation as described by others
(McGrath et al., 2008), and representative ﬂow cytometry density
plots are shown (Fig. 1E). No difference in differentiation was
observed between day 7 erythroblasts from normal controls and
α-thalassemia 1 carriers (Fig. 1F), with the majority of cells being
proerythroblast (R1) and basophilic erythroblasts (R2). A signiﬁ-
cantly higher level of basophilic erythroblasts were seen in day 10
α-thalassemia 1 trait cells as compared to normal controls
(p¼ 0.013; Fig. 1G), but as no difference in infection was seen in
day 10 erythroblasts, the difference is unlikely to be of signiﬁcance
in the infection process.
DENV-2 replication in erythroid committed precursor cells
Evidence from ﬂow cytometry is consistent with infection of
erythroid committed precursor cells for both normal controls and
thalassemia traits. However, the antibody used to determine the
degree of infection is directed against a structural protein (the
E protein) and therefore it is possible that positive cells reﬂect
internalized virus without viral replication occurring. To exclude
this possibility, cells were investigated for expression of dengue
non-structural protein 1 (NS1) whose expression results from
translation of the viral genomic RNA and is absolutely required
for viral replication (Muller and Young, 2013). Day 7 and day 10
erythroblasts from normal controls and thalassemia carriers of Hb
E, β-thalassemia and α-thalassemia 1 were either infected with
DENV-2 or mock infected and at day 2 p.i. proteins were extracted
and used in western analysis. Results (Fig. 2A) showed the clear
expression of NS1 in all DENV-2 infected cells. DENV NS1 protein is
found intracellularly and as a membrane associated and secreted
hexameric form which is composed of heat labile amphipathic
dimeric subunits (Gutsche et al., 2011; Pryor and Wright, 1993). To
detect secreted DENV NS1, supernatants from day 7 mock and
infected erythroblasts were separated by electrophoresis and sub-
jected to western blot analysis after transfer to solid matrix support.
Dimeric NS1 was observed in infected supernatants which were
heated at 80 1C and was not present in 100 1C boiled protein
(Fig. 2B). Erythroblasts are cultured in medium containing human
AB serum, and thus it was not possible to observe the monomeric
form due to cross reaction from the secondary antibody used in the
western blot. However, the blot was stripped and re-probed with
secondary antibody only to serve as a loading control (Ig in Fig. 2B).
Moreover, expression of NS1 protein was clearly evident in DENV-2
infected cells when normal infected and mock infected erythro-
blasts were stained with an anti-NS1 monoclonal antibody and an
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appropriate ﬂuorescent secondary antibody and examined under a
confocal microscope (Fig. 2C). A greater number of NS1 positive
cells were observed in day 7 infected erythroblasts than day 10
erythroblasts (Fig. 2C), consistent with the data on infection levels
in these cells obtained by ﬂow cytometry.
DENV-2 production from erythroid committed precursor cells
To show that DENV-2 infection of erythroid committed precursor
cells was productive, day 7 and 10 erythroid committed precursor
cells from three normal controls were infected with DENV-2 under
standard conditions and virus production determined by standard
plaque assay at multiple time points post infection. Virus titer of
erythroblasts infected on day 7 showed a peak of virus production
between 2 and 3 days post infection (Fig. 2D), after which virus titer
gradually decreased. A similar trend was found when infecting day
10 erythroblasts, but the titer was lower than that observed for day
7 erythroblasts (Fig. 2E). In all cases a drop in virus titer as compared
to the infecting titer was seen at 12 h post infection, reﬂecting
internalization of the virus into cells. Again, in all cases virus titer was
higher at 24 h.p.i as compared to 12 h.p.i, reﬂecting de novo virus
production.
Effects of DENV-2 infection on erythroid committed precursor cells
To determine the effects of DENV infection on erythroid com-
mitted precursor cells, day 7 normal control cells and α-thalassemia
1 trait cells were infected with DENV-2 and at 48 h p.i. examined for
Fig. 1. DENV-2 infection and differentiation of erythroid cells. Direct (open bars) and ADE mediated (solid bars) DENV-2 infection of K562 cells (A) and day 4 erythroid progenitor
cells (B) as assessed by ﬂow cytometry. DENV-2 infection (solid bars) and mock infection (open bars) of day 7 (C) and day 10 (D) erythroid committed precursor cells from normal
controls (N), Hb E trait (E), β-thalassemia trait (β) and α-thalassemia-1 trait (α). Differentiation of day 7 and day 10 normal control and α-thalassemia-1 trait erythroid committed
precursor cells was assessed by ﬂow cytometry after staining with antibodies directed against CD 71 and glycophorin A. Representative ﬂow cytometry density plots are shown (E).
Regions were gated as 1 (predominantly proerythroblasts), 2 (predominantly basophilic erythroblasts), 3 (predominantly polychromatophilic erythroblasts) and 4 (predominantly
orthchromatophilic erythroblasts) as shown and data from three experiments was plotted as histograms for day 7 (F) and day 10 (G). Error bars represent SD (n; po0.05).
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differentiation, cell number and cell apoptosis. While no difference in
differentiation was seen in normal control erythroblasts (Fig. 3A),
α-thalassemia 1 trait cells showed a signiﬁcant difference in differ-
entiation in response to infection with trait cells showing a sig-
niﬁcant reduction in state of differentiation (Fig. 3B). With respect to
cell number, both normal control and α-thalassemia 1 trait day
7 infected cells showed a signiﬁcant deﬁcit in response to DENV
infection as compared to uninfected cells (Fig. 3C and D), while only
α-thalassemia 1 trait cells showed a deﬁcit on cells infected on day
10 (Fig. 3E and F). Cell apoptosis as assessed by propidium iodide and
annexin V staining was increased in both day 7 infected normal
control and α-thalassemia 1 trait erythroblasts as compared to mock
infected, consistent with the deﬁcit seen in cell number, while no
signiﬁcant difference was observed between day 10 infected and
uninfected erythroblasts irrespective of trait status (Fig. 4).
Erythroid differentiation stage and DENV-2 infection
To determine the susceptibility for DENV-2 infection of each
erythroid cell stage, day 7 and day 10 erythroid precursor cells
were generated from three normal controls, three β-thalassemia
trait and 3 Hb E trait carriers and were stained with an anti-DENV
NS1 antibody followed by a biotinylated secondary antibody and
the chromogenic signal ﬁnally developed using DAB. Cells were
subsequently counterstained with Wright–Giemsa staining to
allow differential counting of cells. A total of 500 cells from each
sample were counted and scored for differentiation and the pre-
sence of NS1. The results showed that NS1 protein was found only
in infected cells (Fig. 5) and that the level of infection correlated
with the earlier ﬂow cytometry analysis in that infection rates
were higher in day 7 cells as compared to day 10 cells and that day
7 erythroblasts from β-trait and HbE trait carriers were reduced
as compared to normal control cells (Table 1). Proerythroblasts
and basophilic erythroblasts were markedly more susceptible to
DENV-2 infection, and susceptibility was reduced at the polychro-
matic erythroblast stage and dramatically dropped at orthochro-
matic erythroblasts (Table 1).
Erythroid committed precursor cells and low passage DENV isolates
As several studies have shown that laboratory adapted DENVs
can show behavior distinct from that of low passage DENV isolates
(Chaichana et al., 2014; Diamond et al., 2000; Edgil et al., 2003),
normal control day 7 erythroid committed precursor cells were
mock infected or infected with DENV-2 high passage (16681) as
used in the previous experiments and a low passage DENV-2 isolate
Fig. 2. DENV-2 replication and production in erythroid precursor cells. (A) Erythroid committed precursor cells from normal control (lanes 1, 5, 9, 13), Hb E trait (lanes 2, 6,
10, 14), β-thalassemia trait (lanes 3, 7, 11, 15) and α-thalassemia-1 trait (lanes 4, 8, 12, 16) were either infected (DENV) or mock infected (Mock) on day 7 and day 10 and
analyzed after 48 h by western blotting for expression of DENV NS1 and GAPDH in a duplex analysis. (B) Supernatants were collected from day 7 erythroid precursor cells of
three normal controls (N1, N2 and N3) at 48 after mock or DENV-2 infection. Protein was heated at either 80 1C or 100 1C and analyzed by western blot for detection secreted
DENV NS1. DENV-2 infected erythroid cells were used as a positive control and heavy chain immunoglobulin (Ig) was used as an internal control. (C) Day 7 and day 10 normal
erythroid committed precursor cells were either infected (DENV) or mock infected (Mock) and at 48 h.p.i. were stained with a mouse monoclonal anti-DENV NS1 protein
antibody followed by a FITC-conjugated secondary antibody (green) and with To-Pro-3 iodide (red) as a nuclear counterstain. Cells were observed under a confocal
microscope. Representative merged images are shown. (D and E) DENV production as assessed by standard plaque assay from day 7 (D) and day 10 (E) erythroid committed
precursor cells after infection with DENV-2. Virus titer in the supernatant was detrmined at the times shown. Normal control 1 (solid circle), normal control 2 (solid square)
and normal control 3 (solid triangle). Error bars represent SD in both panels.
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and a low passage DENV-4 isolate and samples were analyzed by
ﬂow cytometry to determine percentage infection. Results showed
high levels of infection with the laboratory adapted virus, but
undetectable levels of infection with the two low passage isolates
(Fig. 6A). To determine more accurately whether any cells had been
infected by the low passage isolates, the normal control cells were
stained with an anti-DENV NS1 antibody and counterstained with
Wright–Giemsa staining as described previously. While infected
cells were clearly evident when the infecting virus was the high
passage, laboratory adapted strain, no cells showing a similar
staining pattern were detected with the low passage strains. How-
ever rare scattered cells were positive for NS1 protein, but the
morphology suggested that these cells were either dead or dying
cells. In this analysis cells were counted before being cytospun onto
the glass slides prior to staining and an apparent deﬁcit was noted in
cell number with cells exposed to the low passage isolates.
To determine if there was a high degree of apoptosis ongoing in
the low passage isolate infections, day 7 erythroid committed pre-
cursor cells from both normal controls and hemoglobin E trait were
therefore either mock infected or infected with the high and low
passage isolates as in the earlier experiment. Cell death was assessed
by propidium iodide and Annexin V staining and subsequent ﬂow
cytometry at 48 h.p.i. Results (Fig. 6C and D) showed signiﬁcantly
higher levels of cell death of normal control erythroid committed
precursor cells infected with low passage DENV-2 as compared to
laboratory adapted DENV-2 (Fig. 6C), and markedly, but not signiﬁ-
cantly higher levels of apoptosis in cells infected with low passage
DENV-4 as compared to laboratory adapted DENV-2. Interestingly,
both low passage isolates induced signiﬁcantly higher levels of
apoptosis in erythroid committed precursor cells from hemoglobin
E trait as compared to the laboratory adapted virus (Fig. 6D). The level
of apoptosis induced by the laboratory adapted DENV-2 was sig-
niﬁcantly higher in hemoglobin E trait cells than in normal control
cells (p¼0.02) consistent with the earlier observation with α-thal-
assemia 1 trait as compared to normal control (Fig. 4).
The results from infection of erythroid committed precursor
cells with low passage isolates of two different serotypes of rare
scattered cells of being positive for NS1, but high levels of cell death
are consistent with the induction of bystander cell death. Bystander
cell death can be mediated by the induction of cytokines such a
tumor necrosis factor alpha (TNF-α) capable of triggering apoptosis
in surrounding, uninfected cells through the activation of death
receptor mediated apoptosis and activation of caspase 8 (Gnesutta
and Minden, 2003). To determine if this was the mechanism behind
Fig. 3. The effect of DENV-2 infection on cell differentiation and cell number. Differentiation of infected (DENV) and mock infected (Mock) day 7 normal control (A) and
α-thalassemia-1 trait (B) erythroid committed precursor cells at 48 h p.i. was assessed by ﬂow cytometry after staining with antibodies directed against CD 71 and
glycophorin A. Regions were gated as described previously and data from three experiments was plotted as histograms. (C–F) Infected (solid bars) and uninfected (open bars)
day 7 (C and D) and day 10 (E and F) erythroid committed precursor cells from normal controls (C and E) and α-thalassemia 1 trait (D and F) were evaluated for cell number
by trypan blue staining at times indicated. Error bars represent SD (n: po0.05; nn po0.01).
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the high levels of cell death seen in response to infection with low
passage isolates, erythroid committed precursor cells from normal
controls were infected with low passage DENV-4 in the presence or
absence of either an inhibitor of caspase 8 or an antibody directed
against tumor necrosis factor receptor 1 (TNF-R1), and at 48 h post
infection both the level of apoptosis and the cell number were
determined. Pre-treatment of cells with a caspase 8 inhibitor both
signiﬁcantly reduced the level of apoptosis (Fig. 6E) and signiﬁ-
cantly increased the cell number (Fig. 6F) as compared to non-
treated cells. Similarly, post treatment of infected cells with an
antibody directed against TNF-R1 signiﬁcantly reduced the level of
apoptosis (Fig. 6G) and signiﬁcantly increased the cell number
(Fig. 6H) as compared to untreated cells.
Discussion
Infection with DENV is a signiﬁcant public health problem in
many tropical and sub-tropical countries of the world and it was
recently estimated that there were nearly 100 million apparent
dengue infections in 2010, together with some 300 million in
apparent infections (Bhatt et al., 2013). To date however there
remains no commercially available vaccine and currently there is
no speciﬁc antiviral drug to treat dengue. Dengue presents with a
wide range of clinical symptoms, and while the disease normally
resolves itself in a few days, it can be associated with life threat-
ening complications (Gubler, 1998).
The target cells of dengue infection remain relatively poorly
characterized, but several cells of the myeloid lineage including den-
dritic cells (Wu et al., 2000), monocytes (Scott et al., 1980), mega-
karyocytes (Noisakran et al., 2012) and erythroid progenitor cells
(Nakao et al., 1989) have been identiﬁed as being targets of dengue
infection. This study conﬁrmed the susceptibility of erythroid pro-
genitor cells to DENV infection using a high passage laboratory strain
of DENV and additionally showed that erythroid committed pre-
cursor cells are also susceptible to DENV infection with the same
strain. The study showed that DENV infection of these cells was
speciﬁc, as we failed to detect infection of these cells with another
mosquito borne virus, namely CHIKV an Alphavirus of the family
Togaviridae. Interestingly, the data showed that maximum suscept-
ibility was observed on day 7 of differentiation, in which the majority
of cells are predominantly basophilic erythroblasts. HSCs cultured
for 4 days (erythroid progenitor) and 10 days (polychromatophilic
erythroblasts and orthochromatic erythroblasts) showed much lower
Fig. 4. The effect of DENV-2 infection on cell death. Erythroid committed precursor cells from normal controls and α-thalassemia 1 traits were evaluated for annexin V and
propidium iodide staining by ﬂow cytometry. Representative ﬂow cytometry density plots are shown (A) while histograms (B and C) show analysis of three independent
experiments. Infected (solid bars) and uninfected (open bars) day 7 (B) and day 10 (C). Error bars represent SD (n; po0.05).
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rates of infection, suggesting that infection may be mediated by a
receptor protein that is transiently expressed around the basophilic
erythroblast stage. Infection of erythroid committed precursor cells
only occurs through direct infection, and we found no evidence of
antibody dependent enhancement of infection as occurs with mono-
cytic cells (Halstead et al., 1980) which corresponds to earlier results
that showed that DENV-4 infection of bone marrow progenitor cells
was not altered by the presence of antibodies (Nakao et al., 1989).
Infection of erythroid precursors with a high passage isolate was
shown to be productive, with de novo virus particles being released
from the infected cells and so these cells can contribute to the
overall level of viraemia which has been shown to be associated
with disease severity (Libraty et al., 2002; Vaughn et al., 2000).
However, while HSCs are found in the peripheral blood, erythroid
committed precursor cells are seldom found in the blood circulation
(Constantino and Bogionis, 2000) and as such these cells are un-
likely to drive the spread of the virus around the body as has been
proposed for megakaryocytes (Noisakran et al., 2012).
Surprisingly, we found a signiﬁcant reduction in the susceptibility
of erythroid committed precursor cells from carriers of thalassemia
traits as compared to normal control cells. The protective effects of
various globin gene expression hemoglobinopathies and gene dele-
tions in respect of the protozoan parasite Plasmodium have beenwell
documented, but this is the ﬁrst report of a similar effect in respect of
a ﬂaviviral infection. The mechanism of protection in thalassemia
carriers remains unclear. In our system both α and β-globin chains
are expressed at low levels on day 7 and show a marked increase in
expression level by day 10 (Leecharoenkiat et al., 2011). This coin-
cides with both the maximum susceptibility of these cells, as well as
the maximum protection seen in trait erythroid precursor cells which
were infected on day 7 and analyzed 48 h later (at day 9). Although
there is no deﬁnitive evidence that thalassemia traits result in a
signiﬁcantly disordered cell processes, it seems likely that even
minor imbalances or disorders in globin synthesis can have wide-
spread cellular consequences. In a recent study on hemoglobin H
Constant Spring (Hb H-CS) we showed alteration of both chaperone
and chaperonin protein expression (Sriiam et al., 2012) and it is
possible that these proteins are also disordered to a lesser extent in
thalassemia carriers, which may impact upon DENV susceptibility.
As with previous studies (Chaichana et al., 2014; Diamond et al.,
2000) we found markedly different consequences when infection
was undertaken with high and low passage viruses. We found
undetectable levels of infection of cells when low passage DENVs
were used as the infecting virus. This is in contrast to the results of
Murgue and colleagues who showed that a prototype DENV-3
isolate (H-87) had no effect on erythroid progenitor cells, while
low passage isolates reduced the growth of the same cells. There are
a number of signiﬁcant differences between the two studies, as
Fig. 5. DENV infection and erythroid stage. Representative ﬁelds of DENV infected and mock infected day 7 and day 10 erythroblasts after immunochromogenic NS1 staining
and counter staining with Wright–Giemsa stain. Cells were observed under a bright ﬁeld microscope and DENV NS1 presents as a brown color in the cytoplasm. Identiﬁed
cells are indicated as proerythroblast (Pro), basophilic erythroblast (Baso), polychromatic erythroblast (Poly) and orthochromatic erythroblast (Ortho).
Table 1
Immunocytochemical staining.
Sample Value Cell stage % NS1
posi-
tivePro Baso Poly Ortho
Day 7 normal control % stage 5.1 25.1 65.8 4.0 79.7
% NS1 100.0 99.6 74.4 3.7
Day 7 β-Thalassemia trait % stage 1.7 14.5 76.7 7.0 49.7
% NS1 89.9 87.4 55.2 0.0
Day 7 Hb E trait % stage 2.2 10.7 73.5 13.6 51.3
% NS1 100.0 100.0 45.6 0.0
Day 10 normal control % stage 1.0 4.8 61.6 32.6 24.3
% NS1 100.0 100.0 44.2 0.0
Day 10 β-Thalassemia trait % stage 0.1 5.1 68.2 31.4 32.0
% NS1 100.0 96.4 40.1 0.0
Day 10 Hb E trait % stage 0.1 0.7 52.2 47.0 12.3
% NS1 100.0 100.0 27.5 0.5
Day 7 and day 10 erythroid committed precursor cells from three normal controls,
three β-thalassemia trait and 3 Hb E trait carriers were stained with anti-DENV NS1
and counterstained by Wright–Giemsa staining. The erythroid cell stage proery-
throblast (Pro), basophilic erythroblast (Baso), polychromatic erythroblast (Poly)
and orthochromatic erythroblast (Ortho) was determined by differential counting
and DENV-NS1 positive cells were identiﬁed and counted for each stage. Data is
shown as the mean of 500 (day 7) or a minimum of 300 (day 10) cells per sample.
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Fig. 6. Clinical isolate DENV infection of erythroid committed precursor cells. The infection of DENV-2 DHF, DENV-4 DF, DENV-2 strain 16681 (positive control), and mock
infected cells (negative control) of day 7 erythroid precursor cells from 3 normal controls (A) was assessed by ﬂow cytometry. Both uninfected (Mock) and DENV infected
erythroid precursor cells were stained with anti-DENV NS1 and counterstained with Wright–Giemsa staining (B). Cell death of day 7 erythroid precursor cells from 2 normal
controls (C) and 3 Hb E traits (D) at 48 h p.i. were evaluated for annexin V and propidium iodide staining by ﬂow cytometry. Cell death (E and G) and cell number (F and H) of
DENV-4 DF infection after 10 mM Caspase 8 inhibitor treatment (E and F) and DENV-2 DHF infection after 0.5 mg⧸mL anti-TNF-R1 treatment (G and H) were determined, all
data were normalized against mock and treated mock. Error bars represent SD (n; po0.05, nn; po0.01, nnn; po0.001).
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Murgue and colleagues (Murgue et al., 1997) investigated erythroid
progenitor cells, while our study focused on erythroid committed
precursor cells, and our study period was two days post infection
while that of Murgue and colleagues (Murgue et al., 1997) was
8 days post infection and the infecting titer was signiﬁcantly lower
in the Murgue and colleagues study (Murgue et al., 1997). It is of
particular note that the study by Murgue and colleagues relied
solely on cell counts, and provided no direct evidence of DENV
infection of these cells (Murgue et al., 1997). While the high in-
fecting titers used in this study may be of some concern, viremia
studies in dengue fever (DF) and dengue hemorrhagic fever (DHF)
patients have shown median peak viremias of 10Log 9.89 and 10.27
for serum of DF and DHF respectively (Tricou et al., 2011), and as
such the titers used in this study are still very far below possible
physiological parameters.
While the low passage viruses showed only scattered cells with
NS1 positive staining indicative of infection, the low passage isolates
induced extremely high levels of cell death as compared to the
laboratory adapted virus. Our data suggests that the cell death is
induced through activation of capases 8 mediated apoptosis in
bystander (uninfected) cells. In this case, although only very few
cells maybe infected, bystander apoptosis may be a signiﬁcant factor
in bone marrow suppression. Our results support that the bystander
apoptosis was mediated by TNF-α, and high levels of TNF-α have
been detected in dengue patients, and levels of TNF-α are believed
to be associated with disease severity (Green and Rothman, 2006;
Hober et al., 1993; Kittigul et al., 2000).
Bystander apoptosis would serve to dampen infection through
removing cells that could otherwise be productively infected adding
to the viral load. It is interesting that committed erythroid precursor
cells from thalassemia trait carriers both showed a reduced sus-
ceptibility to the laboratory adapted virus, as well as markedly
increased levels of cell death with low passage isolates as compared
to normal control committed erythroid precursor cells. Both of
these observations would support that the presence of a thalasse-
mia trait may protect in a small way against severe dengue disease.
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